RB1 and neoplasm: Perturbations in nuclear architecture (e.g., altered lamin A/C expression) and chromatin repositioning could modulate the accessibility of oncogenes (e.g., CCND1) or tumor suppressors (e.g., TP53, RB1) in oncogenesis.